PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1178516
PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1178516
Global molecular diagnostics services market is projected to register a substantial CAGR of 7.9% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Market Segmentation
Global Molecular Diagnostics Services Market, By Service Type (Instrument Repair Services, Training Services, Compliance Services, Calibration Services, Maintenance Services, Scalable Automation Services, Turnkey Services, Instrument Relocation Services, Hardware Customization, Performance Assurance Services, Design and Development Services, Supply Chain Solutions, New Product Introduction Services, Manufacturing Services, Environmental & Regulatory Services, Medical Management Systems Certification & Auditing, Clinical Research Services, Consultative Services, and Other Services), Technology (PCR, Real Time PCR, Next Generation Sequencing, and Other Technologies), End User (Hospitals, Diagnostic Centers, Academic & Research Institutions, and Others), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Netherlands, Russia, Denmark, Switzerland, Turkey, Sweden, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, New Zealand, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Ethiopia, UAE, and Rest of Middle East and Africa) Industry Trends and Forecast to 2030.
Increasing demand for testing, therapies, and faster diagnostics
Growing funding in the molecular diagnostics segment
Market Players
F. Hoffmann-La Roche Ltd
Danaher
BIOMERIEUX
QIAGEN
Thermo Fisher Scientific
Bio-Rad Laboratories, Inc
Abbott
DiaSorin S.p.A
Hologic, Inc